Antra Zeltina

Antra Zeltina has extensive experience in research and development, particularly in molecular design and antibody engineering. At Octapharma, from August 2018 to January 2022, Antra held the position of Group Manager R&D Molecular Design and Lead Discovery, focusing on budgeting and antibody engineering, and previously served as a Scientist in the same area. Antra's academic background includes a Marie Curie Postdoctoral Researcher role at the University of Oxford (March 2014 - May 2018), where expertise was developed in the structural and functional characterization of viral antigen-antibody complexes, therapeutic antibodies, and collaborations with various research entities. Antra completed a PhD in Molecular Biology at ETH Zurich (January 2009 - December 2013), and has a strong foundation in biophysics and molecular bioengineering, complemented by earlier research on mitochondrial DNA mutations and membrane transport proteins.